| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| EXEL | EXELIXIS, INC. | President and CEO, Director | $130M | Nov 11, 2025 | ||
| VERA | Vera Therapeutics, Inc. | Director | May 14, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|